MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) is advancing toward commercial deployment of its voice-based artificial intelligence platform for detecting drug and alcohol impairment, with a focus on industrial safety applications in South America’s mining sector. The biotechnology company recently appointed Chilean policy specialist Felipe Leyton to lead commercialization efforts in the region, a move that signals MindBio’s transition from technology development to field implementation in large enterprise environments.
Leyton brings experience in national drug policy and workplace safety, having helped design and implement Chile’s ‘Zero Tolerance’ alcohol-impaired driving law as part of the country’s alcohol prevention framework. He also played a role in establishing Chile’s roadside drug testing program introduced in 2019. His appointment reflects MindBio’s strategy of aligning technical development with regulatory and industry expertise in markets where impairment detection is closely tied to workplace safety and compliance requirements.
The AI prediction model uses over 50 million data points to predict alcohol intoxication with remarkable accuracy, just by using the human voice. The company is developing an enterprise platform including Edge-AI kiosks integrating bespoke hardware and software for the detection of drug and alcohol intoxication using the human voice and AI in a range of enterprise environments including the mining industry, aviation, construction and law enforcement.
This move is significant for the mining sector, particularly in South America, where worker safety is paramount. Impairment from drugs or alcohol can lead to accidents and fatalities in high-risk environments like mines. By deploying a non-invasive, voice-based detection system, companies can screen employees quickly and accurately without requiring blood or saliva samples, reducing downtime and improving workplace safety.
The implications extend beyond mining. As the technology matures, it could be adopted in other industries such as aviation, where pilot impairment is a critical concern, and construction, where heavy machinery operation requires full alertness. Law enforcement agencies may also utilize the platform for roadside testing, building on Chile’s existing roadside drug testing program.
MindBio’s focus on the South American market leverages Leyton’s regulatory background and the region’s mining dominance. Chile is the world’s largest copper producer, and mining accounts for a significant portion of its GDP. Implementing advanced safety technologies could reduce accident rates and associated costs, potentially influencing global safety standards.
For more information, see the full article at https://ibn.fm/JBNVq and the company’s newsroom at https://ibn.fm/MBQIF.
